What's your position on ?
Why are you ish?
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Aug. 18, 2015, 1:28 PM
Jul. 16, 2015, 12:31 PM
- UniQure (QURE -0.1%) initiated with Outperform rating by Cowen & Co.
- Axovant Sciences (AXON +2.7%) initiated with Market Outperform rating and price target of $36 (103% upside) by JMP Securities.
- Walgreens Boots Alliance (WBA +1.6%) upgraded to Outperform from Neutral by Credit Suisse. Price target raised to $110 (15% upside) from $90.
- Celgene (CELG +3.1%) maintained with Buy rating by Nomura. Price target raised to $165 (22% upside) from $146. Receptos (RCPT -0.3%) downgraded to Neutral from Buy with a $232 (predictable) price target.
Jul. 15, 2015, 12:36 PM
- Moody's raises its outlook on the U.S. retail industry to Positive from Stable on its view operating income will improve by 5% to 6% over the next 12 to 18 months.
- The ratings agency is focused on the expense side, seeing a leveraging of fixed costs and efficiency gains as helping to pad bottom lines.
- Sectors seen leading the way for profit growth are dollar stores (FDO, DG, DLTR), drug stores (WBA, CVS, RAD), and home improvement chains (HD, LOW).
- Related ETFs: XLY, XRT, VCR, RTH, RETL, IYK, FXD, FDIS, RCD, PMR, UGE, SZK
Jul. 10, 2015, 8:31 AM
Jul. 9, 2015, 8:10 AM
- Walgreens Boots Alliance (NASDAQ:WBA) names Stefano Pessina as its permanent CEO, earning praise for overseeing the integration of Walgreens and Boots Alliance that is "proceeding exceptionally well."
- Pessina, formerly executive chairman at Alliance Boots, served as interim CEO of the newly-merged company following the retirement of former Walgreens CEO Greg Wasson, who left after the merger was completed last year.
- Separately, WBA says it has acquired U.K.-based natural skin care brand Liz Earle Beauty from Avon (NYSE:AVP) for £140M.
- Earlier: Walgreens Boots Alliance's FQ3
Jul. 9, 2015, 7:28 AM
- Walgreens Boots Alliance (NASDAQ:WBA) reports comparable-store sales rose 1.6% in FQ3.
- Pharmacy sales grew 7% on a 3.8% gain in prescription count for the quarter.
- Gross profit margin rate decreased 206 bps to 26%.
- Adjsuted SG&A expense rate -240 bps to 20.1%.
- Adjusted operating margin rate fell 22 bps to 6.07%.
- Total drugstores count +8 Q/Q to 8,240.
- FY2015 Guidance: Adjusted EPS: $3.70 to $3.80.
- FY2016 Guidance: Adjusted EPS: $4.25 to $4.60.
- WBA +2.72% premarket.
Jul. 9, 2015, 7:01 AM
- Walgreens Boots (NASDAQ:WBA): FQ3 EPS of $1.02 beats by $0.15.
- Revenue of $28.79B (+48.4% Y/Y) misses by $840M.
Jul. 8, 2015, 5:30 PM
Jun. 1, 2015, 10:42 AM
- Walgreens Boots Alliance (WBA -0.8%) announced Anthony Roberts will take over as the company's global chief information officer to replace Tim Theriault.
- Theriault will stay on with Walgreens as a consultant and senior advisor.
- The transition becomes effective tomorrow.
May 21, 2015, 11:07 AM
- Rite Aid (RAD +1.5%) and Walgreens Boots Alliance (WBA +2.1%) trade higher after CVS Health snaps up Omnicare in a $12.7B deal.
- Analysts think the merger could be a positive factor for prescription pricing in the sector.
- Previously: Bloomberg: CVS in advanced talks to buy Omnicare (May 20)
- Previously: CVS Health strikes deal for Omincare (May 21)
May 21, 2015, 9:17 AM
- New additions to Goldman's hedge fund hotels - 50 stocks which most frequently appear among the largest ten holdings of hedge funds: AerCap (NYSE:AER), Assured Guaranty (NYSE:AGO), Baker Hughes (NYSE:BHI), Citizens Financial (NYSE:CFG), Colony Capital (NYSE:CLNY), Dresser-Rand (NYSE:DRC), Family Dollar (NYSE:FDO), Hospira (NYSE:HSP), Netflix (NASDAQ:NFLX), NXP Semi (NASDAQ:NXPI), Pharmacyclics (NASDAQ:PCYC), Visa (NYSE:V), and Walgreens (NASDAQ:WBA).
- Since 2001, the basket has outperformed the S&P 500 in 66% of quarters by an average of 73 basis points. YTD, however, it has underperformed by nine bps. Goldman notes the current basket overweights Consumer Discretionary (22%) and underweights Consumer Staples (2%).
- Looking at the full list, Actavis (NYSE:ACT) leads the way, with 77 funds naming the stock as a top 10 holding. Next up is Apple (NASDAQ:AAPL) with 69, then Facebook (NASDAQ:FB) at 42. For the entire list of 50, the average is 26 funds making a stock a top 10 holding.
- The rest in order: Valeant (NYSE:VRX), Microsoft (NASDAQ:MSFT), DirecTV (NASDAQ:DTV), Citigroup (NYSE:C), Time Warner (NYSE:TWC), Delta (NYSE:DAL), Cheneire (NYSEMKT:LNG), Yahoo (NASDAQ:YHOO), Liberty Global (NASDAQ:LBTYK), AIG, SunEdison (NYSE:SUNE), Air Products (NYSE:APD), Amazon (NASDAQ:AMZN), GM, BofA (NYSE:BAC), JPMorgan (NYSE:JPM), Macquarie Infrastructure (NYSE:MIC), American Airlines (NASDAQ:AAL), Charter Communications (NASDAQ:CHTR), Google (GOOG, GOOGL), Ally Financial (NYSE:ALLY), NorthStar Realty (NYSE:NRF), Priceline (NASDAQ:PCLN), eBay (NASDAQ:EBAY), MasterCard (NYSE:MA), Alibaba (NYSE:BABA), Micron (NASDAQ:MU), Williams (NYSE:WMB), Gilead (NASDAQ:GILD), Berkshire Hathaway (BRK.A, BRK.B), Dolar General (NYSE:DG), NorthStar Asset (NYSE:NSAM), Brookdale Senior (NYSE:BKD), DISH Network (NASDAQ:DISH).
- See also: Goldman updates list of hedge funds most-shorted stocks (May 21)
May 20, 2015, 11:48 AM| May 20, 2015, 11:48 AM | 1 Comment
Apr. 30, 2015, 4:08 PM
- According to Bloomberg, the list of firms that have indicated an interest in Omnicare (NYSE:OCR) include Express Scripts (NASDAQ:ESRX), CVS Health (NYSE:CVS), Walgreens Boots Alliance (NASDAQ:WBA) and McKesson (NYSE:MCK). Initial bids for the $8.5B market cap firm are due in May.
- Previously: Omnicare reportedly exploring sale; trading halted (April 22)
- Previously: Omnicare buyer would need to pay $95/share - UBS (April 23)
Apr. 23, 2015, 7:41 AM
- UBS estimates a buyer would have to pay $95 to acquire Omnicare (NYSE:OCR).
- Firm thinks Walgreens (NASDAQ:WBA) or Rite Aid (NYSE:RAD) could be interested, but are unlikely to pay up due to limited synergies.
- OCR increased management comp. in the event of a change in control, a possible indicator the company may be sold.
- Previously: Omnicare reportedly exploring sale; trading halted (Apr. 22)
Apr. 15, 2015, 2:10 PM| Apr. 15, 2015, 2:10 PM | 5 Comments
Apr. 14, 2015, 10:24 AM
- A lawsuit filed last week by a pension fund holding a stake in Walgreen Boots Alliance (WBA -0.1%) contends the company misled investors over the benefits of the Walgreen-Boots Alliance merger.
- The case was filed against the merged Walgreen Co. and its former CFO and CEO.
- The company hasn't responded publicly to the allegations.
Walgreens Boots Alliance Inc operates drug-stores chain in the United States. It provides consumer goods and services, pharmacy, and health and wellness services through drug-stores, as well as mail, and by telephone and online.
Other News & PR